title: Proteomic analysis of laser microdissected melanoma cells from skin organ cultures.
abstract: Gaining insights into the molecular events that govern the progression from melanoma in situ to advanced melanoma and understanding how the local microenvironment at the melanoma site influences this progression are two clinically pivotal aspects that to date are largely unexplored. In an effort to identify key regulators of the crosstalk between melanoma cells and the melanoma-skin microenvironment, primary and metastatic human melanoma cells were seeded into skin organ cultures (SOCs) and grown for two weeks. Melanoma cells were recovered from SOCs by laser microdissection and whole-cell tryptic digests were analyzed by nanoflow liquid chromatography-tandem mass spectrometry. The differential protein abundances were calculated by spectral counting, the results of which provides evidence that cell-matrix and cell-adhesion molecules that are upregulated in the presence of these melanoma cells recapitulate proteomic data obtained from comparative analysis of human biopsies of invasive melanoma and a tissue sample of adjacent, noninvolved skin. This concordance demonstrates the value of SOCs for conducting proteomic investigations of the melanoma microenvironment.
authors.affiliation: Department of Pharmacology & Chemical Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh, PA, USA.
authors.forename: Brian L
authors.initials: BL
authors.lastname: Hood
authors.forename: Jelena
authors.initials: J
authors.lastname: Grahovac
authors.forename: Melanie S
authors.initials: MS
authors.lastname: Flint
authors.forename: Mai
authors.initials: M
authors.lastname: Sun
authors.forename: Nuno
authors.initials: N
authors.lastname: Charro
authors.forename: Dorothea
authors.initials: D
authors.lastname: Becker
authors.forename: Alan
authors.initials: A
authors.lastname: Wells
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Conrads
mesh_terms: D000185:Actinin / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D008545:Melanoma / Q000378:metabolism*; D042282:Microdissection; D040901:Proteomics / Q000379:methods*; D012867:Skin / Q000166:cytology; D053719:Tandem Mass Spectrometry; D019063:Tenascin / Q000378:metabolism; D046509:Tissue Culture Techniques / Q000379:methods*; D014407:Tumor Cells, Cultured / Q000378:metabolism*
chemical_list: C111453:ACTN4 protein, human; D019063:Tenascin; D000185:Actinin
references.citation: J Proteome Res. 2009 May;8(5):2501-10
references.pmid: 19222175
references.citation: J Biol Chem. 2010 Jan 22;285(4):2591-600
references.pmid: 19920151
references.citation: J Cancer Res Clin Oncol. 2009 Sep;135(9):1257-64
references.pmid: 19288131
references.citation: Z Naturforsch B. 1970 Mar;25(3):332-3
references.pmid: 4392802
references.citation: J Cell Commun Signal. 2009 Dec;3(3-4):189-200
references.pmid: 19798599
references.citation: Crit Rev Oncol Hematol. 2004 Mar;49(3):245-58
references.pmid: 15036264
references.citation: Am Fam Physician. 1989 May;39(5):203-14
references.pmid: 2655407
references.citation: Clin Cancer Res. 2008 Feb 15;14(4):1002-14
references.pmid: 18281532
references.citation: Eur J Cancer. 2008 Dec;44(18):2760-5
references.pmid: 19026532
references.citation: Clin Exp Metastasis. 2003;20(8):685-700
references.pmid: 14713103
references.citation: J Cell Physiol. 2008 Feb;214(2):504-12
references.pmid: 17708541
references.citation: Histopathology. 2004 Oct;45(4):405-11
references.pmid: 15469480
references.citation: Nat Methods. 2007 Mar;4(3):207-14
references.pmid: 17327847
references.citation: Cancer Sci. 2010 Feb;101(2):523-9
references.pmid: 19930159
references.citation: J Clin Invest. 2001 Apr;107(8):929-34
references.pmid: 11306593
references.citation: Dev Dyn. 2000 Jun;218(2):235-59
references.pmid: 10842355
references.citation: Br J Dermatol. 2000 Feb;142(2):210-22
references.pmid: 10730751
references.citation: Cancer Res. 2001 Jun 1;61(11):4642-3
references.pmid: 11389102
references.citation: Biochim Biophys Acta. 2009 Feb;1794(2):159-67
references.pmid: 18996230
references.citation: Crit Rev Biochem Mol Biol. 1989;24(1):41-67
references.pmid: 2667895
references.citation: Cancer Microenviron. 2008 Dec;1(1):93-102
references.pmid: 19308688
references.citation: BMC Med Genomics. 2008 Apr 28;1:13
references.pmid: 18442402
references.citation: J Med. 2004;35(1-6):141-9
references.pmid: 18084872
references.citation: PLoS One. 2009;4(4):e5199
references.pmid: 19381273
references.citation: J Pathol. 2006 Oct;210(2):181-91
references.pmid: 16924594
references.citation: Pigment Cell Res. 2000;13 Suppl 8:68-72
references.pmid: 11041360
references.citation: Proteomics. 2008 Nov;8(22):4733-47
references.pmid: 18942674
references.citation: J Cell Biol. 1996 Nov;135(4):991-1007
references.pmid: 8922382
references.citation: Cell Mol Life Sci. 2008 Sep;65(17):2688-701
references.pmid: 18488141
references.citation: Nature. 1996 Feb 1;379(6564):466-9
references.pmid: 8559255
references.citation: Methods Mol Biol. 2005;289:61-70
references.pmid: 15502170
references.citation: Cancer Res. 1995 Oct 1;55(19):4283-6
references.pmid: 7671236
references.citation: Anal Chem. 2004 Jul 15;76(14):4193-201
references.pmid: 15253663
references.citation: J Invest Dermatol. 2001 Nov;117(5):1042-9
references.pmid: 11710911
references.citation: Am J Pathol. 2000 Jan;156(1):193-200
references.pmid: 10623667
references.citation: J Invest Dermatol. 1991 Jul;97(1):20-6
references.pmid: 2056188
references.citation: J Gastrointest Surg. 2009 Nov;13(11):1948-54; discussion 1954
references.pmid: 19760374
references.citation: J Cancer Res Clin Oncol. 2008 Nov;134(11):1219-27
references.pmid: 18446369